BG103933A - 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate - Google Patents
5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleateInfo
- Publication number
- BG103933A BG103933A BG103933A BG10393399A BG103933A BG 103933 A BG103933 A BG 103933A BG 103933 A BG103933 A BG 103933A BG 10393399 A BG10393399 A BG 10393399A BG 103933 A BG103933 A BG 103933A
- Authority
- BG
- Bulgaria
- Prior art keywords
- ethyl
- methyl
- tetrazol
- tetrahydropyridine
- maleate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention relates to an adjunctive salt of the maleic acid of 2-ethyl-5-(1-methyl-1,2,3,6-tetrahydro-3-pyridyl)-2H- tetrazole, to pharmaceutical compositions containing the adjunctive with acid salt, and to its application in the treatment of disorders caused by dysfunction of the acetylcholine (AcCh) or muscarine system.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK78197 | 1997-07-01 | ||
PCT/DK1998/000294 WO1999001448A1 (en) | 1997-07-01 | 1998-07-01 | 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
Publications (1)
Publication Number | Publication Date |
---|---|
BG103933A true BG103933A (en) | 2000-07-31 |
Family
ID=8097489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103933A BG103933A (en) | 1997-07-01 | 1999-11-30 | 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0994869A1 (en) |
JP (1) | JP2002507215A (en) |
KR (1) | KR20010014297A (en) |
CN (1) | CN1261361A (en) |
AR (1) | AR013096A1 (en) |
AU (1) | AU735751B2 (en) |
BG (1) | BG103933A (en) |
BR (1) | BR9810331A (en) |
CA (1) | CA2293324A1 (en) |
CO (1) | CO4940483A1 (en) |
EA (1) | EA200000081A1 (en) |
HU (1) | HUP0002876A2 (en) |
IL (1) | IL133093A0 (en) |
IS (1) | IS5278A (en) |
JO (1) | JO2031B1 (en) |
MA (1) | MA25138A1 (en) |
NO (1) | NO996580D0 (en) |
PE (1) | PE116099A1 (en) |
PL (1) | PL337184A1 (en) |
SK (1) | SK187399A3 (en) |
TN (1) | TNSN98120A1 (en) |
TR (1) | TR199903283T2 (en) |
UY (2) | UY25069A1 (en) |
WO (1) | WO1999001448A1 (en) |
ZA (1) | ZA985498B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
PL326490A1 (en) * | 1995-11-06 | 1998-09-28 | Lundbeck & Co As H | Treatment of traumatic brain injuries |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/en not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/en unknown
- 1998-06-25 PE PE1998000563A patent/PE116099A1/en not_active Application Discontinuation
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-26 CO CO98036576A patent/CO4940483A1/en unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/en not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/en unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/en active Pending
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/en not_active Application Discontinuation
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/en unknown
- 1998-07-01 IL IL13309398A patent/IL133093A0/en unknown
- 1998-07-01 MA MA25155A patent/MA25138A1/en unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 CN CN98806497A patent/CN1261361A/en active Pending
- 1998-07-01 PL PL98337184A patent/PL337184A1/en unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/en not_active Application Discontinuation
- 1998-07-01 EA EA200000081A patent/EA200000081A1/en unknown
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/en unknown
- 1998-07-01 SK SK1873-99A patent/SK187399A3/en unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/en not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/en unknown
- 1999-11-30 BG BG103933A patent/BG103933A/en unknown
- 1999-12-30 NO NO996580A patent/NO996580D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999001448A1 (en) | 1999-01-14 |
PE116099A1 (en) | 1999-11-23 |
CO4940483A1 (en) | 2000-07-24 |
EA200000081A1 (en) | 2000-08-28 |
SK187399A3 (en) | 2000-06-12 |
TNSN98120A1 (en) | 2005-03-15 |
KR20010014297A (en) | 2001-02-26 |
UY25069A1 (en) | 1998-12-21 |
JO2031B1 (en) | 1999-05-15 |
NO996580L (en) | 1999-12-30 |
TR199903283T2 (en) | 2000-06-21 |
IL133093A0 (en) | 2001-03-19 |
AU735751B2 (en) | 2001-07-12 |
UY25177A1 (en) | 2000-12-29 |
CA2293324A1 (en) | 1999-01-14 |
PL337184A1 (en) | 2000-08-14 |
AR013096A1 (en) | 2000-12-13 |
IS5278A (en) | 1999-11-30 |
AU8102098A (en) | 1999-01-25 |
MA25138A1 (en) | 2001-04-02 |
NO996580D0 (en) | 1999-12-30 |
BR9810331A (en) | 2000-09-05 |
EP0994869A1 (en) | 2000-04-26 |
CN1261361A (en) | 2000-07-26 |
JP2002507215A (en) | 2002-03-05 |
HUP0002876A2 (en) | 2001-06-28 |
ZA985498B (en) | 1999-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69528823D1 (en) | Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten | |
MXPA04002982A (en) | Pyrrolidinone derivatives. | |
CA2297911A1 (en) | Substituted 6-phenylphenanthridines | |
EP2767291A3 (en) | Treatment of glycogen storage disease type II | |
PL361341A1 (en) | Novel pharmaceutical composition | |
YU59098A (en) | Substituted spiro-piperidine derivatives | |
PT1053256E (en) | Antibodies to death receptor 4 (dr4) and uses thereof | |
MY134806A (en) | Cyclosporins | |
ATE300533T1 (en) | 1,2,3,4-TETRAHYDROISOCINOLINE DERIVATIVES AS UROTENSIN II RECEPTOR ANTAGONISTS | |
BG102425A (en) | (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors | |
EP1808177A3 (en) | Methods of treatment of mitochondrial disorders | |
TR200000015T2 (en) | Compounds and methods | |
HUT73807A (en) | 5-ht1-like indole derivatives and pharmaceutical compositions containing them | |
CA2250569A1 (en) | Novel phenanthridines substituted in the 6 position | |
IL146448A0 (en) | Dr4 antibodies and uses thereof | |
AU1753699A (en) | Application of vasopressin antagonists for treating disturbances or illnesses ofthe inner ear | |
DE69919179D1 (en) | SUBSTITUTED GAMMA-PHENYL-DELTA-LACTONE AND THEIR ANALOGS, AND THEIR USE | |
CA2058592A1 (en) | Antibacterial agents | |
BG105256A (en) | Muscarinic agonists and antagonists | |
BG105761A (en) | Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents | |
CA2161533A1 (en) | Indole Derivatives | |
WO2001010408A3 (en) | Aqueous pharmaceutical composition containing moxifloxacin or salts thereof | |
GR3031261T3 (en) | Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy. | |
IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease |